Cardiovascular

NIH teams up with Siemens on MRI with lower magnetic field for cardiac, lung imaging

October 2, 2019

Looking to help patients requiring imaging of lungs or other internal structures, researchers from the NIH and Siemens Healthineers AG, of Erlangen, Germany, have developed a high-performance, low magnetic-field magnetic resonance imaging (MRI) system that also could prove safer for those with pacemakers or defibrillators.

Study finds Orchestra Biomed's Backbeat device reduces hypertension

October 1, 2019

By Stacy Lawrence

No Comments

Intact's vascular scaffold hits endpoints in above-the-knee European study

October 1, 2019

By Meg Bryant

No Comments

Abbott unveils positive data on Mitraclip, Triclip

October 1, 2019

By Liz Hollis

No Comments

Abbott Laboratories had a busy Transcatheter Cardiovascular Therapeutics (TCT) 2019 conference. Among the news it generated was the unveiling of new analyses of the COAPT trial on the cost-effectiveness of Mitraclip vs. guideline-directed medical therapy (GDMT) alone in heart failure patients with secondary mitral regurgitation (MR).

Abbott's pivotal trial results for Portico boosted by new delivery system

September 30, 2019

By Stacy Lawrence

No Comments

Investigator-led study finds BSX's Acurate Neo not noninferior vs. Edwards' Sapien 3

September 30, 2019

By Stacy Lawrence

No Comments

SAN FRANCISCO – As the transcatheter aortic valve replacement (TAVR) field matures, it is becoming increasingly difficult to develop a new implant that can distinguish itself vs. competitors. The incremental benefits are narrowing rapidly, making it tough to distinguish new iterations from one another using standard, randomized trials.

Shockwave reports positive registry data on pre-stent calcium fracture via IVL

September 27, 2019

By Stacy Lawrence

No Comments

Huinno secures KRW8.3B for series A investment

September 27, 2019

By Jihyun Kim

No Comments

Pascal holds own in one-year CLASP data, as speculation abounds on Mitraclip comparisons

September 27, 2019

By Stacy Lawrence

No Comments

SAN FRANCISCO – Mitraclip from Abbott Park, Ill.-based Abbott Laboratories, has long been the only minimally invasive mitral valve repair device that's approved by the FDA. Edwards Lifesciences Corp., of Irvine, Calif., aims to challenge that dominance with its Pascal. This week at the Transcatheter Cardiovascular Therapeutics (TCT) conference, positive one-year data from the small CLASP study on Pascal were presented, offering a further glimpse of data for comparison.

Data, analytics and Dx crucial as medical device industry transforms into med tech

September 26, 2019

By Stacy Lawrence

No Comments

Cardiovascular, BioWorld MedTech
RSS

NIH teams up with Siemens on MRI with lower magnetic field for cardiac, lung imaging

Study finds Orchestra Biomed's Backbeat device reduces hypertension

Intact's vascular scaffold hits endpoints in above-the-knee European study

Abbott unveils positive data on Mitraclip, Triclip

Abbott's pivotal trial results for Portico boosted by new delivery system

Investigator-led study finds BSX's Acurate Neo not noninferior vs. Edwards' Sapien 3

Shockwave reports positive registry data on pre-stent calcium fracture via IVL

Huinno secures KRW8.3B for series A investment

Pascal holds own in one-year CLASP data, as speculation abounds on Mitraclip comparisons

Data, analytics and Dx crucial as medical device industry transforms into med tech

Popular Stories

Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop

China launches price war to reshuffle pharma industry; Bayer cuts prices by 90% to secure market

Thiel calls for improving research grant, regulatory processes to enhance scientific innovation

Year in Review: From capital markets to CRISPR, 2019 a pretty good year for biopharma

Novavax developing nanoparticle vaccine for Wuhan coronavirus

BioWorld Premium

Cardiovascular, BioWorld MedTech RSS

Popular Stories

BioWorld Premium

Cardiovascular, BioWorld MedTech
RSS